MedaPhor Group plc

('the Group' the 'Company')

Patent Infringement Settlement

Further to the statement made by the Company on 27 April 2016 (RNS No. 4638W: Notice of Patent Infringement Proceedings), the Group subsidiaries, MedaPhor Limited and MedaPhor North America Inc. (collectively 'MedaPhor'), announce that MedaPhor and SonoSim Inc. and The Regents of the University of California have reached an agreement in principle on a patent license and patent infringement settlement. As a result, the parties will proceed to formalize their agreement in writing, following which the lawsuit between the parties will be dismissed.

The settlement will be satisfied from the existing cash resources of the Group. The Company will provide a further update on the settlement once all documents are finalised.

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulations which came into effect on 3 July 2016.

Enquiries:

MedaPhor Group plc

www.medaphor.com

Stuart Gall, CEO

Tel: +44 (0)29 2075 6534

Cenkos Securities

Tel: +44 (0)20 7397 8900

Bobbie Hilliam (Nominated Adviser)

Julian Morse (Corporate Broking)

Walbrook PR

Tel: +44 (0)20 7933 8780 ormedaphor@walbrookpr.com

Paul McManus / Anna Dunphy

Mob: +44 (0)7980 541 893 / Mob: +44 (0)7876 741 001

Medaphor Group plc published this content on 16 December 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 16 December 2016 08:08:06 UTC.

Original documenthttps://www.medaphor.com/patent-infringement-settlement/

Public permalinkhttp://www.publicnow.com/view/7042514860793936D310B120DD98A02C4353A499